Visioli Fernanda, Wang Yugang, Alam Goleeta N, Ning Yu, Rados Pantelis V, Nör Jacques E, Polverini Peter J
Department of Biologic and Materials Sciences, University of Michigan School of Dentistry, Ann Arbor, Michigan, United States of America; Department of Conservative Dentistry, Universidade Federal do Rio Grande do Sul School of Dentistry, Porto Alegre, Rio Grande do Sul, Brazil.
Department of Biologic and Materials Sciences, University of Michigan School of Dentistry, Ann Arbor, Michigan, United States of America.
PLoS One. 2014 Jun 25;9(6):e101053. doi: 10.1371/journal.pone.0101053. eCollection 2014.
This study was designed to investigate the activation of the unfolded protein response (UPR) in tumor associated endothelial cells (TECs) and its association with chemoresistance during acidic pH stress.
Endothelial cells from human oral squamous cell carcinomas (OSCC) were excised by laser capture microdissection (LCM) followed by analysis of UPR markers (Grp78, ATF4 and CHOP) using quantitative PCR. Grp78 expression was also determined by immunostaining. Acidic stress was induced in primary human dermal microvascular endothelial cells (HDMECs) by treatment with conditioned medium (CM) from tumor cells grown under hypoxic conditions or by adjusting medium pH to 6.4 or 7.0 using lactic acid or hydrochloric acid (HCl). HDMEC resistance to the anti-angiogenic drug Sunitinib was assessed with SRB assay.
UPR markers, Grp78, ATF4 and CHOP were significantly upregulated in TECs from OSCC compared to HDMECs. HDMECs cultured in acidic CM (pH 6.0-6.4) showed increased expression of the UPR markers. However, severe acidosis led to marked cell death in HDMECs. Alternatively, HDMECs were able to adapt when exposed to chronic acidosis at pH 7.0 for 7 days, with concomittant increase in Grp78 expression. Chronic acidosis also confers drug resistance to HDMECs against Sunitinib. Knockdown of Grp78 using shRNA resensitizes HDMECs to drug treatment.
UPR induction in ECs under acidic pH conditions is related to chemoresistance and may contribute to therapeutic failures in response to chemotherapy. Targeting Grp78, the key component of the UPR pathway, may provide a promising approach to overcome ECs resistance in cancer therapy.
本研究旨在调查肿瘤相关内皮细胞(TECs)中未折叠蛋白反应(UPR)的激活情况及其在酸性pH应激期间与化疗耐药性的关联。
通过激光捕获显微切割(LCM)从人口腔鳞状细胞癌(OSCC)中分离出内皮细胞,随后使用定量PCR分析UPR标志物(Grp78、ATF4和CHOP)。还通过免疫染色确定Grp78的表达。通过用缺氧条件下培养的肿瘤细胞的条件培养基(CM)处理,或使用乳酸或盐酸(HCl)将培养基pH调节至6.4或7.0,在原代人真皮微血管内皮细胞(HDMECs)中诱导酸性应激。用SRB法评估HDMECs对抗血管生成药物舒尼替尼的耐药性。
与HDMECs相比,OSCC的TECs中UPR标志物Grp78、ATF4和CHOP显著上调。在酸性CM(pH 6.0 - 6.4)中培养的HDMECs显示UPR标志物的表达增加。然而,严重酸中毒导致HDMECs中明显的细胞死亡。另外,当HDMECs暴露于pH 7.0的慢性酸中毒7天时能够适应,同时Grp78表达增加。慢性酸中毒还使HDMECs对舒尼替尼产生耐药性。使用shRNA敲低Grp78可使HDMECs对药物治疗重新敏感。
酸性pH条件下内皮细胞中的UPR诱导与化疗耐药性相关,可能导致化疗治疗失败。靶向UPR途径的关键成分Grp78,可能为克服癌症治疗中内皮细胞耐药性提供一种有前景的方法。